These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9352546

  • 1. Quantification of IBZM dopamine receptor SPET in de novo Parkinson patients before and during therapy.
    Hertel A, Weppner M, Baas H, Schreiner M, Maul FD, Baum RP, Fischer PA, Hör G.
    Nucl Med Commun; 1997 Sep; 18(9):811-22. PubMed ID: 9352546
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonism.
    Schwarz J, Antonini A, Tatsch K, Kirsch CM, Oertel WH, Leenders KL.
    Nucl Med Commun; 1994 Oct; 15(10):806-13. PubMed ID: 7838444
    [Abstract] [Full Text] [Related]

  • 4. Lateralized differences in iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease.
    Knable MB, Jones DW, Coppola R, Hyde TM, Lee KS, Gorey J, Weinberger DR.
    J Nucl Med; 1995 Jul; 36(7):1216-25. PubMed ID: 7790947
    [Abstract] [Full Text] [Related]

  • 5. Alterations of striatal dopamine D2 receptors contribute to deteriorated response to L-dopa in Parkinson's disease: a [123I]-IBZM SPET study.
    Pizzolato G, Chierichetti F, Rossato A, Cagnin A, Fabbri M, Dam M, Ferlin G, Battistin L.
    J Neural Transm Suppl; 1995 Jul; 45():113-22. PubMed ID: 8748616
    [Abstract] [Full Text] [Related]

  • 6. [The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients].
    Hierholzer J, Cordes M, Schelosky L, Barzen G, Poewe W, Henkes H, Keske U, Horowski R, Felix R.
    Rofo; 1992 Oct; 157(4):390-8. PubMed ID: 1391843
    [Abstract] [Full Text] [Related]

  • 7. [Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms].
    Bettin S, Kämpfer I, Seese A, Schäfer A, Reuter M, Lössner J, Dietrich J, Wagner A, Knapp WH.
    Nuklearmedizin; 1997 Aug; 36(5):167-72. PubMed ID: 9380528
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of D2 receptor scintigraphy (123I-IBZM) with cerebral perfusion (99m-Tc-HMPAO) in extrapyramidal disorders].
    Saur HB, Bartenstein P, Schober O, Oberwittler C, Lerch H, Masur H.
    Nuklearmedizin; 1994 Oct; 33(5):184-8. PubMed ID: 7997375
    [Abstract] [Full Text] [Related]

  • 9. Iodine-123-IBF SPECT evaluation of extrapyramidal diseases.
    Buck A, Westera G, Sutter M, Albani C, Kung HF, vonSchulthess GK.
    J Nucl Med; 1995 Jul; 36(7):1196-200. PubMed ID: 7790944
    [Abstract] [Full Text] [Related]

  • 10. SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease.
    Tatsch K, Schwarz J, Oertel WH, Kirsch CM.
    Nucl Med Commun; 1991 Aug; 12(8):699-707. PubMed ID: 1838142
    [Abstract] [Full Text] [Related]

  • 11. Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease.
    Seppi K, Schocke MF, Donnemiller E, Esterhammer R, Kremser C, Scherfler C, Diem A, Jaschke W, Wenning GK, Poewe W.
    Mov Disord; 2004 Dec; 19(12):1438-45. PubMed ID: 15390073
    [Abstract] [Full Text] [Related]

  • 12. 123I-IBZM SPECT: reconstruction methodology and results in parkinsonism and dystonia.
    Berding G, Gratz KF, Kolbe H, Meyer GJ, Dengler R, Knoop BO, Hundeshagen H.
    Nuklearmedizin; 1994 Oct; 33(5):194-9. PubMed ID: 7997377
    [Abstract] [Full Text] [Related]

  • 13. Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT.
    Schelosky L, Hierholzer J, Wissel J, Cordes M, Poewe W.
    Mov Disord; 1993 Oct; 8(4):453-8. PubMed ID: 8232354
    [Abstract] [Full Text] [Related]

  • 14. [Initial experiences with 123-Iodine-IBZM neuroreceptor scintigraphy in extrapyramidal disorders].
    Pávics L, Dibó G, Ambrus E, Séra T, Vécsei L, Csernay L.
    Orv Hetil; 2000 May 14; 141(20):1073-7. PubMed ID: 10851890
    [Abstract] [Full Text] [Related]

  • 15. Dopamine receptor SPET imaging in Parkinson's disease: a [123I]-IBZM and [99mTc]-HM-PAO study.
    Pizzolato G, Chierichetti F, Rossato A, Briani C, Dam M, Borsato N, Saitta B, Zanco P, Ferlin G, Battistin L.
    Eur Neurol; 1993 May 14; 33(2):143-8. PubMed ID: 8467821
    [Abstract] [Full Text] [Related]

  • 16. Dopamine D2 receptor occupancy measured by single photon emission computed tomography with 123I-Iodobenzamide in chronic schizophrenia.
    Volk S, Maul FD, Hör G, Schreiner M, Weppner M, Holzmann T, Pflug B.
    Psychiatry Res; 1994 Jun 14; 55(2):111-8. PubMed ID: 10711799
    [Abstract] [Full Text] [Related]

  • 17. Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.
    Hierholzer J, Cordes M, Venz S, Schelosky L, Harisch C, Richter W, Keske U, Hosten N, Mäurer J, Poewe W, Felix R.
    J Nucl Med; 1998 Jun 14; 39(6):954-60. PubMed ID: 9627325
    [Abstract] [Full Text] [Related]

  • 18. Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography.
    van Royen E, Verhoeff NF, Speelman JD, Wolters EC, Kuiper MA, Janssen AG.
    Arch Neurol; 1993 May 14; 50(5):513-6. PubMed ID: 8489409
    [Abstract] [Full Text] [Related]

  • 19. [The differential diagnosis of Parkinson diseases--123I-IBZM-SPECT vs. the apomorphine test].
    Hierholzer J, Cordes M, Schelosky L, Sander B, Böck JC, David I, Horowski R, Poewe W.
    Rofo; 1993 Jul 14; 159(1):86-90. PubMed ID: 8334264
    [Abstract] [Full Text] [Related]

  • 20. [Cerebral SPECT with iodine-123 IBZM in patients with extrapyramidal system disorders: the evaluation of its sensitivity in therapy with dopaminergic drugs].
    Hierholzer J, Castelli L, Cordes M, Schelosky L, Poewe W, Felix R.
    Radiol Med; 1996 Mar 14; 91(3):207-10. PubMed ID: 8628932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.